GB0204713D0 - Long acting injectable parasiticidal composition - Google Patents

Long acting injectable parasiticidal composition

Info

Publication number
GB0204713D0
GB0204713D0 GBGB0204713.2A GB0204713A GB0204713D0 GB 0204713 D0 GB0204713 D0 GB 0204713D0 GB 0204713 A GB0204713 A GB 0204713A GB 0204713 D0 GB0204713 D0 GB 0204713D0
Authority
GB
United Kingdom
Prior art keywords
long acting
acting injectable
parasiticidal composition
injectable parasiticidal
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0204713.2A
Other versions
GB2386067A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norbrook Laboratories Ltd
Original Assignee
Norbrook Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Laboratories Ltd filed Critical Norbrook Laboratories Ltd
Priority to GB0204713A priority Critical patent/GB2386067A/en
Publication of GB0204713D0 publication Critical patent/GB0204713D0/en
Priority to PCT/GB2003/000535 priority patent/WO2003072112A1/en
Priority to AU2003205858A priority patent/AU2003205858A1/en
Priority to ARP030100641A priority patent/AR038853A1/en
Publication of GB2386067A publication Critical patent/GB2386067A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB0204713A 2002-02-28 2002-02-28 Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species Withdrawn GB2386067A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB0204713A GB2386067A (en) 2002-02-28 2002-02-28 Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
PCT/GB2003/000535 WO2003072112A1 (en) 2002-02-28 2003-02-12 'long'-'acting' injectable parasiticidal composition
AU2003205858A AU2003205858A1 (en) 2002-02-28 2003-02-12 "long"-"acting" injectable parasiticidal composition
ARP030100641A AR038853A1 (en) 2002-02-28 2003-02-27 AN INJECTABLE PARASITICIATED COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0204713A GB2386067A (en) 2002-02-28 2002-02-28 Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species

Publications (2)

Publication Number Publication Date
GB0204713D0 true GB0204713D0 (en) 2002-04-17
GB2386067A GB2386067A (en) 2003-09-10

Family

ID=9931979

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0204713A Withdrawn GB2386067A (en) 2002-02-28 2002-02-28 Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species

Country Status (4)

Country Link
AR (1) AR038853A1 (en)
AU (1) AU2003205858A1 (en)
GB (1) GB2386067A (en)
WO (1) WO2003072112A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7666444B2 (en) 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
BRPI0511847B1 (en) 2004-06-07 2014-09-16 Syngenta Participations Ag METHODS OF REDUCING DAMAGE TO PLANT PROPAGATION MATERIAL AND PLANT ORGANS AND IMPROVING PEST CONTROL THAT ENABLE SOIL DIRECTED TO A PLANT BY A PESTICIDE
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
BRPI0506279B1 (en) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda SYNERGY COMPOSITION OF ANTIHELMINTICS AND NON-DECATED
BRPI0705822A2 (en) * 2007-10-25 2009-06-23 Schering Plough Saude Animal Ltda long-acting injectable formulation and use of a semisynthetic agent derived from the avermectin group in combination with a biodegradable polymer
WO2015093924A1 (en) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Issac Vehicle for the administration of pharmaceutical compounds
WO2019050259A1 (en) * 2017-09-06 2019-03-14 (주)인벤티지랩 Microparticles comprising moxidectin, and preparation method therefor
KR102101969B1 (en) 2017-09-06 2020-04-22 (주)인벤티지랩 Microparticles containing moxidectin and method for manufacturing same
CN109966438A (en) * 2019-05-17 2019-07-05 石家庄九鼎动物药业有限公司 A kind of antiparasite drugs for animals ivermectin injection and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223200A (en) * 1988-01-15 1989-01-06 Ancare Distributors Anthelmintic compositions containing 2',5-dicloro-4'-nitrosalicylanilide and non aqueous carrier
CN1054504C (en) * 1993-03-15 2000-07-19 科尔加特·帕尔莫利弗公司 Antibacterial antiplaque oral composition
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
US6193989B1 (en) * 1997-03-21 2001-02-27 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions

Also Published As

Publication number Publication date
WO2003072112A1 (en) 2003-09-04
AR038853A1 (en) 2005-01-26
GB2386067A (en) 2003-09-10
AU2003205858A1 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
AP2004003142A0 (en) Long acting parasiticidal composition
GB0305941D0 (en) Composition
EP1559433A4 (en) Stabilized composition
GB0302738D0 (en) Composition
HK1096621A1 (en) Parasiticidal composition
GB0324918D0 (en) Composition
GB0204713D0 (en) Long acting injectable parasiticidal composition
GB0324897D0 (en) Composition
HK1087034A1 (en) Actacid composition
GB0322033D0 (en) Composition
MY145151A (en) Composition
GB2404587B (en) Parasiticidal composition
GB0309317D0 (en) Composition
GB0324295D0 (en) Composition
GB0306312D0 (en) Composition
GB0219419D0 (en) Parasiticidal composition
GB0326815D0 (en) Composition
GB0301869D0 (en) Composition
GB0323207D0 (en) Composition I
GB0323335D0 (en) Composition
GB0317504D0 (en) Composition
GB0315769D0 (en) Immunigenic composition
GB0312468D0 (en) Composition
GB0311810D0 (en) Composition
GB0311465D0 (en) Composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)